Discover 511 paid clinical trials in New Orleans, Louisiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 511
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
for
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
Location: New Orleans LA, Shreveport LA, Little Rock AR,
Sponsor: NRG Oncology
Sex: All
Age: 45 - 70
Code: NCT05080673
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
for
NonSegmental Vitiligo
Location: New Orleans LA, Birmingham AL, Bellaire TX,
Sponsor: Incyte Corporation
Sex: All
Age: 2 - 11
Code: NCT06548360
Phase3, Recruiting
Multilevel Intervention for LDCT Lung Cancer Screening and Smoking Cessation Among African Americans
for
Lung Cancer Screening, Tobacco Use Disorder, Smoking Cessation
Location: New Orleans LA
Sponsor: Louisiana State University Health Sciences Center in New Orleans
Sex: All
Age: 50 - 70+
Code: NCT07576595
Recruiting
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
for
Rectal Cancer
Location: New Orleans LA, Covington LA, Houston TX, Germantown TN,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT06205485
Phase3, Recruiting
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
for
Heart Failure
Location: New Orleans LA, Houma LA, Lafayette LA, Fairhope AL,
Sponsor: Cordio Medical
Sex: All
Age: 22+
Code: NCT06378632
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
for
HER2-negative Breast Cancer
Location: New Orleans LA, Houston TX, Orlando FL, Louisville KY,
Sponsor: NSABP Foundation Inc
Sex: Female
Age: 18+
Code: NCT03412643
Phase2, Recruiting
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: New Orleans LA, Birmingham AL, Houston TX, Columbus GA,
Sponsor: United Therapeutics
Sex: All
Age: 18+
Code: NCT06388421
Recruiting
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
for
Endometrial Cancer
Location: New Orleans LA, Houston TX, Atlanta GA, Decatur GA,
Sponsor: Canadian Cancer Trials Group
Sex: Female
Age: 18+
Code: NCT05640999
Phase2, Recruiting
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for
Breast Cancer
Location: New Orleans LA, Daphne AL, Pensacola FL, Houston TX,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06492616
Phase3, Recruiting
Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer
for
Stage I Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,
Location: New Orleans LA, League City TX, Houston TX, Conroe TX,
Sponsor: NRG Oncology
Sex: Female
Age: 18+
Code: NCT06388018
Phase2, Recruiting
Video Laryngoscopy Versus Direct Laryngoscopy for Nasotracheal Intubation
for
Intubation, Intratracheal
Location: New Orleans LA
Sponsor: Louisiana State University Health Sciences Center in New Orleans
Sex: All
Age: 18+
Code: NCT03775317
Recruiting
Endothelial Biomarkers of Systemic Sclerosis-associated Pulmonary Hypertension
for
Scleroderma, Pulmonary Hypertension
Location: New Orleans LA
Sponsor: Louisiana State University Health Sciences Center in New Orleans
Sex: All
Age: 18+
Code: NCT03459716
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: New Orleans LA, Jackson MS, Grenada MS, Columbus MS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06498635
Phase3, Recruiting
The CoAGulation Biomarkers and Atrial Fibrillation (COAG-AF) Pilot Study